Vis enkel innførsel

dc.contributor.advisorBjørnsen, Thomas
dc.contributor.advisorTonstad Vårvik, Fredrik
dc.contributor.authorGrannes Martinsen, Nils Johan
dc.date.accessioned2023-01-10T17:23:21Z
dc.date.available2023-01-10T17:23:21Z
dc.date.issued2022
dc.identifierno.uia:inspera:126731495:70484894
dc.identifier.urihttps://hdl.handle.net/11250/3042497
dc.descriptionFull text not available
dc.description.abstractThe use of ergogenic compounds has gained increasing popularity among athletes who wish to improve athletic performance and recover faster from their workouts. Among these products is Citrulline Malate (CitMal); a precursor to nitric oxide (NO) that promises to enhance blood flow to exercising muscles. To evaluate the purported effect on blood flow we assessed blood flow in the arm of 12 healthy, recreationally active men (23 ± 3 years) pre and post intake of placebo, 6 and 12 grams CitMal, with measurements done 1 and 2 hours post intake. The experiment was conducted as a randomized, double-blind and placebo-controlled crossover study with ≥ 7-day washout-period between each of the three sessions. Blood flow was measured directly with ultrasound doppler in the reactive hyperemic state (FLOW) and indirectly by assessing the dilator capacity of the brachial artery (a. brachialis) in the active hyperemic state (FMD). Repeated measures ANOVA revealed no statistically significant change in FLOW or FMD 1 and 2 hours post intake of placebo, 6 and 12 grams CitMal compared to baseline values. The measurement data were also not statistically significantly different between the groups at any of the measurement times, neither for FLOW nor FMD. Out of the 12 participants, 8 of them underwent blood assessments after all blood flow measurements were completed to assess the dose-response relationship between CitMal (6 and 12 grams, time window: 0-120 min) and blood markers involved in the production of NO. Independent t-test revealed statistically significant higher serum levels of arginine and higher ratio-values between arginine and its methylated derivatives symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA) at all measurement times after consumption of 6 and 12 grams of CitMal compared to baseline values. Taken together, these data provide evidence that CitMal does not increase blood flow to musculature in the active- nor reactive hyperemic state in young healthy males with normal blood levels of arginine. Keywords: Citrulline Malate, nitric oxide, blood flow, arginine, symmetric- and asymmetric dimethylarginine.
dc.description.abstract
dc.language
dc.publisherUniversity of Agder
dc.titleEffekten av Citrulline Malate på blodstrøm hos unge friske menn
dc.typeMaster thesis


Tilhørende fil(er)

FilerStørrelseFormatVis

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel